Schedule 13D ownership disclosure

HARPOON THERAPEUTICS INC

Security class unavailable · CUSIP: 41358P106

Event date: 2023-03-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
8.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-23-083705
Form type
SC 13D/A
Filer
Arix Bioscience plc
CIK
CIK 1700449
Filed
Mar 29, 2023
Reporting period
Mar 23, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub